Rona Therapeutics Signs Global RNAi Licensing Agreement with Roche Worth Up to $1.16 Billion in Milestones

PartnershipPositive

AI Analysis

Summary

Rona Therapeutics signed a global RNAi licensing agreement with Roche with potential milestone payments up to $1.16 billion. The deal represents a significant partnership in the RNAi therapeutic space.

Outcome Details

Global RNAi licensing agreement

Importance:7/10

Sentiment:

0.80

licensingpartnershipRNAimilestone payments

Related Companies

$RHHBY

Read the original article

Published by yahoo_finance on October 13, 2026 2:05 PM

Read Original